As the cryptocurrency market sums up a volatile Q3, the effect of trends and events on this market in Q4 remains uncertain. Amidst this environment, the much-anticipated launch of the new online cryptocurrency trading brand EarningCrypt has been announced. As of, the provider’s website, platform and infrastructure are open to users from around the world. According to the company’s spokesperson, Jeremy Atkins, no minimum fee or deposit is required in order to register.
“With this new platform, we wanted to further democratize the concept of cryptocurrency trading,” explained Atkins, “so it will be as accessible as possible to a wide global population, whilst remaining committed to strict security policies. That’s why we’ve also deployed the strictest encryption codes in the industry today, so as to ensure all personal finances and information are as safe as they can be. We know that our clients’ privacy and safety are no matter to be taken light-heartedly, and I can assure our traders that we’ve made every effort possible to adhere to the strictest policies in that sense.”
Recommended AI News: Acxiom Builds Innovative Marketing Platform for Toyota’s Move Away From Cookies
A trading experience that suits you
As conditions in the cryptocurrency markets are constantly changing, it seems that ‘traditional’ trading brands are having a hard time keeping up with new protocols and measures. That’s why, sadly, so many of these brands do not offer the most optimal trading experience to their clients. For that reason, EarningCrypt has left and will leave no stone unturned in its efforts to always stay updated and innovative, for the sake of its users.
This proactive approach is already reaping the fruits, as hundreds of traders from around the world have already registered with the brand in its first days of operation. “We would like to thank all of our new partner traders for choosing us over our competitors,” added Atkins. “We promise never to take their trust for granted.”
Recommended AI News: Broad Institute, Intel, Google Advance Biomedical Research
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.